Evaluation of the association of pseudoaldosteronism with licorice-containing herbal medicine using the Japanese adverse drug event report (JADER) database
Clinical Snapshot
PICO Framework
| P — Population | Patients reported in the Japanese Adverse Drug Event Report (JADER) database between April 2004 and December 2024 (961,171 reports) |
| I — Intervention | Licorice-containing herbal medicines (Kampo preparations) |
| C — Comparator | Overall herbal medicines group and non-licorice containing preparations |
| O — Outcomes | Pseudoaldosteronism (PT code: 10037113) with 537 reported cases |
Bottom Line
This pharmacovigilance study of nearly one million Japanese adverse event reports identifies a clear association between licorice-containing herbal medicines and pseudoaldosteronism, with a dose-response relationship and clinical threshold of 1.125 g/day. While the spontaneous reporting methodology limits causal inference and confounder control, the large dataset and standardised outcome definition provide valuable safety signals. The findings support existing clinical concerns about licorice-induced mineralocorticoid effects and provide the first quantitative risk assessment from Asian populations. Clinicians prescribing or advising on Kampo preparations should monitor for hypertension, hypokalaemia, and oedema, particularly with daily licorice intake exceeding 1.1 g. The study's limitations include potential underreporting, lack of exposure validation, and limited confounder adjustment inherent to spontaneous reporting databases. Despite these constraints, the dose-response relationship and biological plausibility support clinical relevance for safety monitoring protocols.
Key Findings
P Value: Not reported in abstract
Effect Size: RORs >1 for all top 20 licorice-containing herbal medicines
Primary Outcome: 537 cases of pseudoaldosteronism identified from 961,171 reports
Nnt Or Sensitivity: ROC analysis: AUC 0.71, sensitivity 84.93%, specificity 44.70%, cutoff 1.125 g/day licorice
Confidence Interval: Not reported in abstract
Clinical Application
Practical threshold of 1.125 g/day licorice provides actionable clinical guidance for monitoring and dose adjustment Relevant to Australian practice where herbal medicines are TGA-regulated. Findings support need for patient education and monitoring protocols for licorice-containing preparations available through pharmacies and practitioners Patients using Kampo or licorice-containing herbal medicines, particularly relevant for complementary medicine practitioners and general practitioners
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Herbal medicine in Japan is known as Kampo preparation, a traditional medicine that combines multiple medicinal herbs and is widely used in medical practice. Pseudoaldosteronism is an issue associated with herbal medicines that contain licorice. However, the relationship between licorice intake and pseudoaldosteronism is not fully understood and is debatable. AIM OF THE STUDY: This study evaluates the association between herbal medicine preparations containing licorice and pseudoaldosteronism using data from the Japanese Adverse Drug Reaction Reporting System (JADER) database. MATERIALS AND METHODS: The JADER database contained 961,171 reports published between April 2004 and December 2024. The association between herbal medicines and pseudoaldosteronism was evaluated using the pharmacovigilance index as the reporting odds ratio (ROR) and logistic regression models. RESULTS: There were 537 cases of pseudoaldosteronism (PT code: 10037113). The reporting ratio of pseudoaldosteronism was higher in the licorice-containing herbal medicines group than in the overall herbal medicines group. The RORs of the top 20 herbal medicines with the highest number of pseudoaldosteronism reports, all of which contained licorice, exceeded one, and a signal was detected. The risk of pseudoaldosteronism increased with increasing licorice intake. According to the receiver operating characteristic (ROC) curve for pseudoaldosteronism (area under the curve (AUC) = 0.71, sensitivity = 0.8493, 1-specificity = 0.5530), the cutoff value was 1.125 g/day. CONCLUSIONS: This study is the first to clarify the association between licorice intake from herbal medicines and pseudoaldosteronism using Japan's spontaneous adverse event-reporting database. These findings will be useful and informative for medical professionals considering treatments with herbal medicines.
References
- 1.Nakao, S., Liao, J., Ino, Y., Oura, K., Ito, S., Kageyama, K., Sato, M., Murakami, Y., Ishida, S., Hirota, T., Endo, S., Uchida, M., Iguchi, K., & Nakamura, M. (2026). Evaluation of the association of pseudoaldosteronism with licorice-containing herbal medicine using the Japanese adverse drug event report (JADER) database. Journal of Ethnopharmacology, 121202. https://doi.org/10.1016/j.jep.2026.121202
Related Research
The Journal of rheumatology
Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review
3 Aug 2026
Journal of medical Internet research
Advancing Human-Centered AI in Clinical Decision Support: Sociocognitive Human-in-the-Loop Study in HIV Care
2 Aug 2026
Journal of psychiatric research
Systematic review of machine learning and deep learning models for EEG-based detection of depression.
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service